These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 548209)

  • 1. Lecithin in the treatment of tardive dyskinesia.
    Branchey MH; Branchey LB; Bark NM; Richardson MA
    Commun Psychopharmacol; 1979; 3(5):303-7. PubMed ID: 548209
    [No Abstract]   [Full Text] [Related]  

  • 2. A crossover study of lecithin treatment of tardive dyskinesia.
    Gelenberg AJ; Dorer DJ; Wojcik JD; Falk WE; Brotman AW; Leahy L
    J Clin Psychiatry; 1990 Apr; 51(4):149-53. PubMed ID: 2182613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind study of lecithin in the treatment of persistent tardive dyskinesia.
    Pérez-Cruet J; Menéndez I; Alvarez-Ghersi J; Falcón JR; Valderrábano O; Castro-Urrutia EC; Ifarraguerri C; Pérez LL
    Bol Asoc Med P R; 1981 Nov; 73(11):531-7. PubMed ID: 6121562
    [No Abstract]   [Full Text] [Related]  

  • 4. Lecithin administration in tardive dyskinesia: clinical and biomedical correlates.
    Jackson IV; Davis LG; Cohen RK; Nuttall EA
    Biol Psychiatry; 1981 Jan; 16(1):85-90. PubMed ID: 7225479
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of tardive dyskinesia with lecithin.
    Jackson IV; Nuttall EA; Ibe IO; Perez-Cruet J
    Am J Psychiatry; 1979 Nov; 136(11):1458-60. PubMed ID: 40440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of tardive dyskinesia by single and repeated application of 7-methoxytacrin.
    Hanus H; Tůtma I; Zapletálek M; Fusek J; Hrdina V
    Homeost Health Dis; 1991; 33(5-6):301-4. PubMed ID: 18265509
    [No Abstract]   [Full Text] [Related]  

  • 7. Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study.
    Miyaoka T; Furuya M; Yasuda H; Hayashida M; Nishida A; Inagaki T; Horiguchi J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):761-4. PubMed ID: 18201810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.
    Bai YM; Yu SC; Lin CC
    J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choline and lecithin for the treatment of tardive dyskinesia [proceedings].
    Gelenberg AJ
    Psychopharmacol Bull; 1979 Apr; 15(2):74-5. PubMed ID: 432384
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of verapamil on tardive dyskinesia and psychosis in schizophrenic patients.
    Reiter S; Adler L; Angrist B; Peselow E; Rotrosen J
    J Clin Psychiatry; 1989 Jan; 50(1):26-7. PubMed ID: 2562952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lithium and lecithin in tardive dyskinesia: an update.
    Volavka J; O'Donnell J; Muragali R; Anderson BG; Gaztanaga P; Boggiano W; Whittaker R; Sta Maria T
    Psychiatry Res; 1986 Oct; 19(2):101-4. PubMed ID: 3538109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin E in the treatment of tardive dyskinesia.
    Akhtar S; Jajor TR; Kumar S
    J Postgrad Med; 1993; 39(3):124-6. PubMed ID: 7914238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia.
    Lohr JB; Caligiuri MP
    J Clin Psychiatry; 1996 Apr; 57(4):167-73. PubMed ID: 8601552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lecithin can suppress tardive dyskinesia.
    Growdon JH; Gelenberg AJ; Doller J; Hirsch MJ; Wurtman RJ
    N Engl J Med; 1978 May; 298(18):1029-30. PubMed ID: 642995
    [No Abstract]   [Full Text] [Related]  

  • 15. Choline and lecithin administration to patients with tardive dyskinesia.
    Growdon JH; Gelenberg AJ
    Trans Am Neurol Assoc; 1978; 103():95-9. PubMed ID: 757093
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of choline and lecithin in the treatment of tardive dyskinesia.
    Zeisel SH; Gelenberg AJ; Growdon JH; Wurtman RJ
    Adv Biochem Psychopharmacol; 1980; 24():463-70. PubMed ID: 6996444
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of reserpine and alpha-methyldopa in the treatment of tardive dyskinesia.
    Huang CC; Wang RI; Hasegawa A; Alverno L
    Psychopharmacol Bull; 1980 Jul; 16(3):41-3. PubMed ID: 7403399
    [No Abstract]   [Full Text] [Related]  

  • 18. Vulnerability to tardive dyskinesia.
    Wolf ME; DeWolfe AS; Ryan JJ; Lips O; Mosnaim AD
    J Clin Psychiatry; 1985 Sep; 46(9):367-8. PubMed ID: 2863257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tardive dystonia and ceruletide effects: case report.
    Sugawara M; Iizuka H; Kawana A; Suzuki J
    Prog Neuropsychopharmacol Biol Psychiatry; 1992 Jan; 16(1):127-34. PubMed ID: 1557504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose diazepam in neuroleptic-resistant schizophrenia with tardive dyskinesia.
    Eapen V; Mukherjee D; Chandra P; Sinha V; Khanna S; Channabasavanna SM
    J Clin Psychiatry; 1989 Aug; 50(8):309. PubMed ID: 2569459
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.